Bruno Lucidi

Executive

US·SEC (Form 4)

Atea Pharmaceuticals, Inc.

Total declarations

Company

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

—

Latest filing published 23 Jun 2026 for Atea Pharmaceuticals, Inc.. Read the official filing

Insider track record

Disclosed buys

Disclosed sells

Signal history

No signal scores available.

Bruno Lucidi: trading record in brief

All filings by Bruno Lucidi on record concern Atea Pharmaceuticals, Inc. The record holds 3 filings, for trades running from 16 June 2024 to 18 June 2026.

Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

On 23 June 2026 came the latest disclosure, an option exercise in Atea Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.